We therefore examined how sensitive the PCa cell lines, including VCaP (p53 mutant R248W), C4-2 (p53 WT), LNCaP (p53 WT), and PC-3 (p53 null), are to these two β-Catenin-CBP interaction disruptors. The gene discussed is CREBBP; the disease is posterior cortical atrophy.